We are live on ! Find out more
AFJKR

Aimei Health Technology Co Right
AFJKR

14 hedge funds and large institutions have $1.16M invested in Aimei Health Technology Co Right in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

15% more capital invested

Capital invested by funds: $1.01M → $1.16M (+$149K)

7% less funds holding

Funds holding: 1514 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

AFJKR Hedge Fund Activity: Q3 2024 in Review

14 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Co Right (AFJKR) for Q3 2024, worth a combined $1.16M — up 15% from $1.01M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of AFJKR and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.

The largest buyer was Cowen and Company, adding an estimated $96.8K. The largest seller was Exos Asset Management, exiting entirely with an estimated $33.7K sold.

  • 14 institutional investors held Aimei Health Technology Co Right (AFJKR) as of Q3 2024, down from 15 in Q2 2024.
  • Funds reported $1.16M of Aimei Health Technology Co Right stock for Q3 2024, up 15% quarter-over-quarter.
  • 0 funds opened new Aimei Health Technology Co Right positions in Q3 2024 and 1 closed out, a net change of -1 holder.
  • The largest Aimei Health Technology Co Right buyer in Q3 2024 was Cowen and Company, an estimated $96.8K added.
  • The largest Aimei Health Technology Co Right seller in Q3 2024 was Exos Asset Management, an estimated $33.7K sold.

Based on aggregated 13F filings for Q3 2024.